Dash Bio
Dash Bio provides automated bioanalysis for preclinical and clinical drug testing.
$30MSeries A
Role not disclosedActivity from announced rounds
Dash Bio provides automated bioanalysis for preclinical and clinical drug testing.
LLM-native platform that processes unstructured clinical docs to surface missed HCC coding opportunities